|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
SINE WEIGHTED MOVING AVERAGE
Trading: SELL @ $3.32
Signal Strength: STRONG
Indicator can be used in isolation or in additional to another technical indicator to confirmation for trading entry. This indicator has the ability to highlight trends across numerous timeframes. This indicator has the ability to smooth historical results to illustrate trend initiation and status. Although this is a simple trend following indicator & can provide good results when coupled with the right indicator. Note, this indicator does not work well in ranging markets producing unwanted whipsaws and false signals.
Opthea (ASX:OPT) currently has a confirmed downtrend. Recent trading has caused the SWMA 15 day average to move below the closing price confirming the short term trend following indicator. Currently, the return on SWMA15 is -2.4%.
A Sine wave is a smooth repetitive oscillation that shifts between a high of y and a low of -y. A SW-MA takes its weighting from the first half of a Sine wave cycle so the largest weighting is given to the data in the middle. The result is very similar to the Triangular Moving Average (Tri-MA) but much more difficult to calculate.
Calculation: Sine Weighted Moving Average (SWMA):
4) S2:=Sin(2*180/6)*Ref(C -1);
5) S3:=Sin(3*180/6)*Ref(C -2);
6) S4:=Sin(4*180/6)*Ref(C -3);
7) S5:=Sin(5*180/6)*Ref(C -4);
PROFILE: Opthea (OPT.AX)
Stock Exchange: ASX
Ticker Codes: | OPT.AX | ASX:OPT |
Opthea Limited develops and commercializes therapies primarily for eye disease in Australia. The company's development activities are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors (VEGF) C and D, and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. Its lead molecule is OPT-302, a soluble form of VEGFR-3, which is in Phase 1/2A clinical trial for the treatment of back of the eye diseases, such as wet age-related macular degeneration that is the cause of blindness in elderly and diabetic populations. The company was formerly known as Circadian Technologies Limited and changed its name to Opthea Limited in December 2015. Opthea Limited is based in South Yarra, Australia.
|PGC Paragon Care||0.29||9.6||1,528,576||-6.9||BEARISH|
|LNG Liquefied Natural Gas||0.12||9.1||340,710||-7||BEARISH|
|OSP Osprey Medical||0.02||6.3||143,313||-19||BEARISH|
|ANG Austin Engineering||0.2||5.3||116,011||-1.5||BEARISH|
|VAH Virgin Australia Holdings||0.13||4||596,964||-6.5||BEARISH|
|RCT Reef Casino||2.41||3.9||1,000||-1||BEARISH|
|TLG Talga Gold||0.45||3.5||218,924||-3.1||BEARISH|